UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 171

of 'Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials'

171
TI
etuximab (IMC-225) plus irinotecan is active in CPT-11-refractory colorectal cancer that expresses epidermal growth factor receptor (abstract)
AU
Saltz L, Rubin M, Hochster H, et AL
SO
Proc Am Soc Clin Oncol. 2001;20:3a.
 
AD